A recent scRNA-seq-based analysis of fibroblastic stromal cells from patients with inflammatory bowel disease has revealed the presence of a CCL19-expressing cell population in the inflamed tissues54. This evidence concerns the gene CCL19 and inflammatory bowel disease.